Mirae Asset Global Etfs Holdings Ltd. Atea Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 39,048 shares of AVIR stock, worth $131,201. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,048Holding current value
$131,201% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AVIR
# of Institutions
113Shares Held
51.8MCall Options Held
71.8KPut Options Held
318K-
Black Rock Inc. New York, NY9.12MShares$30.6 Million0.0% of portfolio
-
Bml Capital Management, LLC Zionsville, IN6.65MShares$22.3 Million13.11% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA5.44MShares$18.3 Million0.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.72MShares$15.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.48MShares$15 Million1.81% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $280M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...